Cargando…
Current and future aspects of TIM-3 as biomarker or as potential targeted in non-small cell lung cancer scope: is there a role in clinical practice?
Autores principales: | De Mello, Ramon Andrade, Zhu, Jin-Hui, Iavelberg, Jairo, Potim, Artur Henrique, Simonetti, Débora, Silva, José Antônio, Castelo-Branco, Pedro, Pozza, Daniel Humberto, Tajima, Carla Chizuru, Tolia, Maria, Antoniou, Georgio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815370/ https://www.ncbi.nlm.nih.gov/pubmed/33489794 http://dx.doi.org/10.21037/tlcr-20-625 |
Ejemplares similares
-
The Role of MET Inhibitor Therapies in the Treatment of Advanced Non-Small Cell Lung Cancer
por: De Mello, Ramon Andrade, et al.
Publicado: (2020) -
Treatment Sequencing Strategies in Lung Cancer
por: Daniel Humberto Pozza,, et al.
Publicado: (2022) -
Advancements of ALK inhibition of non-small cell lung cancer: a literature review
por: Zia, Victor, et al.
Publicado: (2023) -
Immunotherapy in Patients with Advanced Non-Small Cell Lung Cancer Lacking Driver Mutations and Future Perspectives
por: De Mello, Ramon Andrade Bezerra, et al.
Publicado: (2021) -
MicroRNAs in Lung Cancer Oncogenesis and Tumor Suppression: How it Can Improve the Clinical Practice?
por: Pozza, Daniel Humberto, et al.
Publicado: (2020)